Dr. Joel Lavine
This prompted him to conduct some studies on genetic vulnerability, hormone receptor profiles, and the impact of sex hormones in NAFLD.
Dr. Lavine observed that a hormone receptor, PPAR-delta, is not expressed as robustly in those with NAFLD but no NASH. They also had decreased inflammation and fat buildup in the liver.
Read More:
This research is expected to result in new NASH treatments and therapies.
